Plasma galectin-3 and heart failure outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).

Stolen, Craig M; Adourian, Aram; Meyer, Timothy E; Stein, Kenneth M; Solomon, Scott D

Stolen, Craig M; Adourian, Aram; Meyer, Timothy E; Stein, Kenneth M; Solomon, Scott D.

Affiliation

Stolen CM; Boston Scientific Corporation, St Paul, Minnesota. Electronic address: craig.stolen@bsci.com.
Adourian A; BG Medicine, Waltham, Massachusetts.
Meyer TE; Boston Scientific Corporation, St Paul, Minnesota.
Stein KM; Boston Scientific Corporation, St Paul, Minnesota.
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

J Card Fail ; 20(11): 793-9, 2014 Nov.

Article in En | MEDLINE | ID: mdl-25106783

Subject(s)

Cardiac Resynchronization Therapy/methods; Defibrillators, Implantable; Galectin 3/blood; Heart Failure/therapy; Aged; Biomarkers/blood; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Failure/blood; Humans; Male; Middle Aged; Prognosis; Treatment Outcome

Key words

Prognosis; biomarkers; cardiac resynchronization therapy; patient selection

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Defibrillators, Implantable / Galectin 3 / Cardiac Resynchronization Therapy / Heart Failure Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google